Patrys (ASX:PAB) finds new mechanism for PAT-DX1 in cancer treatment
Patrys (PAB) sees a range of PAT-DX1 studies published in peer-reviewed journal…
Patrys Limited (ASX:PAB)
About Patrys Limited
Key Information
PAB In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 14/06/2022 | Price Sensitive PS New Mechanism By Which PAT-DX1 May Reduce Cancer Metastasis | 295.27KB | 26K |
| 03/06/2022 | Price Sensitive PS CBCF funding to support deoxymab brain cancer development | 308.87KB | 5.7K |
| 11/05/2022 | Patrys CEO to present at Bioshares Biotech Summit | 15.42MB | 10K |
| 28/04/2022 | Price Sensitive PS Appendix 4C - Quarterly - 31 March 2022 | 504.72KB | 8.8K |
| 26/04/2022 | Patrys strengthens executive team on path to clinic | 221.07KB | 3.5K |
| 14/04/2022 | Section 708A Cleansing Statement | 166.29KB | 1.1K |
| 14/04/2022 | Application for quotation of securities - PAB | 24.9KB | 354 |
| 28/02/2022 | Price Sensitive PS Stable Cell Line for Production of PAT-DX3 Established | 188.9KB | 37K |